Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Windtree Therapeutics Inc (NQ: WINT )

3.200 +0.030 (+0.95%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 17, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 348,993
Open 3.140
Bid (Size) 3.180 (1)
Ask (Size) 3.300 (8)
Prev. Close 3.170
Today's Range 3.140 - 3.360
52wk Range 2.750 - 27.00
Shares Outstanding 5,148,219
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
What's Going On With Windtree Therapeutics Stock Wednesday?
Windtree Therapeutics shares are trading higher Wednesday after the company completed enrollment of its SEISMiC Extension Phase 2b study of istaroxime. 
Via Benzinga
Why Recursion Pharmaceuticals Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga

Performance

YTD
-74.53%
-74.53%
1 Month
-70.91%
-70.91%
3 Month
-3.27%
-3.27%
6 Month
-49.21%
-49.21%
1 Year
-83.23%
-83.23%

More News

Read More
WINT Stock Earnings: Windtree Therapeutics Reported Results for Q1 2024
Via InvestorPlace
(WINT) - Analyzing Windtree Therapeutics's Short Interest
Via Benzinga
Why Is Windtree Therapeutics (WINT) Stock Up 116% Today?
Via InvestorPlace
(WINT) - Analyzing Windtree Therapeutics's Short Interest
Via Benzinga
Why Windtree Therapeutics (WINT) Stock Is Volatile Today
Via Benzinga
S&P 500 Gains Over 1%; 3M Shares Jump After Q2 Results
Via Benzinga
Topics Stocks
Exposures US Equities
Why Saia Shares Are Trading Lower? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Crude Oil Down Over 2%; Bristol Myers Squibb Posts Upbeat Q2 Results
Via Benzinga
Exposures Fossil Fuels
Dow Surges 550 Points; Headline PCE Price Index Falls To 2.5%
Via Benzinga
Topics Stocks
Exposures US Equities
What's Going On With Windtree Therapeutics Stock?
Via Benzinga
Topics Regulatory Compliance
Exposures Legal Regulatory
Why Is DexCom (DXCM) Stock Down 38% Today?
Via InvestorPlace
Why Is BurgerFi International (BFI) Stock Up 71% Today?
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
Why Ultra Clean Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
Why Windtree Therapeutics (WINT) Stock Is Getting Hammered
Via Benzinga
Why Las Vegas Sands Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
WINT Stock Earnings: Windtree Therapeutics Beats EPS for Q4 2023
Via InvestorPlace
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Windtree Therapeutics – This Biotech Inks License Deal For Lead Candidate
Via Benzinga
Windtree Therapeutics (NASDAQ:WINT) Eliminates $15 Million Contingent Liability To Deerfield Management Company
Via ACCESSWIRE
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Windtree Therapeutics (NASDAQ: WINT) Eliminates $15 Million Contingent Liability To Deerfield Management Company
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.